Recent analysis reveals a significant surge in venture capital funding for digital health startups during the first half of 2026, highlighting a trend towards larger investments concentrated among fewer companies.
According to Rock Health, U.S. digital health firms secured $7.4 billion across 244 deals, surpassing the $6.4 billion raised in a similar timeframe last year. The median deal size increased from $12 million to $14 million, with mega-deals (valued at $100 million or more) constituting 45% of total funding. This resurgence follows a downturn in 2022, attributed to inflation and other economic pressures, but interest in artificial intelligence (AI) tools has reignited investor enthusiasm.
In the first quarter, startups raised $4.2 billion, followed by $3.2 billion in the second quarter. Mental health remains the leading area for investment, while weight management startups have gained traction due to the popularity of GLP-1 weight loss medications. The integration of AI in digital health is becoming ubiquitous, prompting investors to seek founders with healthcare backgrounds who can better navigate market challenges and buyer expectations.
This trend towards AI not only facilitates the creation of diverse products but also encourages strategic partnerships, as companies strive to meet rising customer demands for effective implementation and measurable returns on investment. Despite the robust funding landscape, the sector is still awaiting more initial public offerings (IPOs), with only seven firms achieving public exits last year and none so far in 2026. The digital health market is also witnessing an increase in acquisitions, with 115 deals recorded in the first half of the year, indicating a shift in growth strategies among startups.